113 related articles for article (PubMed ID: 3496995)
1. Studies on the pathogenesis of murine experimental autoimmune active hepatitis: sensitized T cell involvement in its induction.
Araki K; Yamamoto H; Fujimoto S
Clin Exp Immunol; 1987 Feb; 67(2):326-34. PubMed ID: 3496995
[TBL] [Abstract][Full Text] [Related]
2. Study of cellular immunity in experimental autoimmune hepatitis in mice: transfer of spleen cells sensitized with liver proteins.
Mori Y; Mori T; Ueda S; Yoshida H; Iesato K; Wakashin Y; Wakashin M; Okuda K
Clin Exp Immunol; 1985 Sep; 61(3):577-84. PubMed ID: 3878243
[TBL] [Abstract][Full Text] [Related]
3. Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae.
Kuriki J; Murakami H; Kakumu S; Sakamoto N; Yokochi T; Nakashima I; Kato N
Gastroenterology; 1983 Mar; 84(3):596-603. PubMed ID: 6218007
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of experimental autoimmune hepatitis in mice--cellular interaction between donor and recipient mice.
Ogawa M; Mori Y; Mori T; Ueda S; Yoshida H; Kato I; Iesato K; Wakashin Y; Azemoto R; Wakashin M
Clin Exp Immunol; 1988 Aug; 73(2):276-82. PubMed ID: 3052945
[TBL] [Abstract][Full Text] [Related]
5. Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity.
Lohse AW; Manns M; Dienes HP; Meyer zum Büschenfelde KH; Cohen IR
Hepatology; 1990 Jan; 11(1):24-30. PubMed ID: 2271015
[TBL] [Abstract][Full Text] [Related]
6. Murine experimental autoimmune hepatitis: nonspecific inflammation due to adjuvant oil.
Howell CD; Yoder TD
Clin Immunol Immunopathol; 1994 Jul; 72(1):76-82. PubMed ID: 8020196
[TBL] [Abstract][Full Text] [Related]
7. Transfer of experimental autoimmune thyroiditis to normal syngeneic mice by injection of mouse thyroglobulin-sensitized T lymphocytes after activation with concanavalin A.
Okayasu I
Clin Immunol Immunopathol; 1985 Jul; 36(1):101-9. PubMed ID: 3874026
[TBL] [Abstract][Full Text] [Related]
8. Experimental autoimmune hepatitis in mice following immunization with syngeneic liver proteins.
Mihas AA; Subramony C; Achord JL
J Med; 1995; 26(5-6):309-22. PubMed ID: 8721906
[TBL] [Abstract][Full Text] [Related]
9. Novel syngeneic liver hapten protein compounds play different roles in pathogenesis of autoimmune hepatitis in the C57BL/6 mouse.
Wen-Ji C; Jin-Hui W; Shu-Bing W; Min Z; Jie C; Zhi-Xun L; Yu-Yuan L; Yu-Qiang N; Min-Hu C
Hepatogastroenterology; 2013 Sep; 60(126):1438-44. PubMed ID: 23933937
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated cytotoxicity of sensitized spleen cells against target liver cells--in vivo and in vitro study with a mouse model of experimental autoimmune hepatitis.
Mori T; Mori Y; Yoshida H; Ueda S; Ogawa M; Iesato K; Wakashin Y; Wakashin M; Okuda K
Hepatology; 1985; 5(5):770-7. PubMed ID: 4029889
[TBL] [Abstract][Full Text] [Related]
11. Experimental hepatitis and role of cytokines.
Tiegs G
Acta Gastroenterol Belg; 1997; 60(2):176-9. PubMed ID: 9260332
[TBL] [Abstract][Full Text] [Related]
12. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
13. Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice.
Watanabe Y; Kawakami H; Kawamoto H; Ikemoto Y; Masuda K; Takezaki E; Nakanishi T; Kajiyama G; Takeno H
Clin Exp Immunol; 1987 Jan; 67(1):105-13. PubMed ID: 3621670
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in experimental autoimmune hepatitis.
Lohse AW; Brunner S; Kyriatsoulis A; Manns M; Meyer zum Büschenfelde KH
J Hepatol; 1992 Jan; 14(1):48-53. PubMed ID: 1737915
[TBL] [Abstract][Full Text] [Related]
15. The appearance of unusual phenotypic cells (CD4+ Mac-1+ class II+) in the liver of (NZW x BXSB)F1 mice is possibly an animal model for autoimmune hepatitis.
Amoh Y; Yasumizu R; Yamamoto Y; Toki J; Nishio N; Adachi Y; Watanabe H; Inoue K; Ikehara S
Immunobiology; 1997 Jun; 197(1):31-43. PubMed ID: 9241529
[TBL] [Abstract][Full Text] [Related]
16. Critical contribution of liver natural killer T cells to a murine model of hepatitis.
Takeda K; Hayakawa Y; Van Kaer L; Matsuda H; Yagita H; Okumura K
Proc Natl Acad Sci U S A; 2000 May; 97(10):5498-503. PubMed ID: 10792025
[TBL] [Abstract][Full Text] [Related]
17. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib attenuates depressive-like behavior associated with immunological liver injury in C57BL/6 mice through TNF-α and NF-κb dependent mechanisms.
ELnahas EM; Zeid MS; Kawy HS; Hendawy N; Baher W
Life Sci; 2016 Oct; 163():23-37. PubMed ID: 27580523
[TBL] [Abstract][Full Text] [Related]
19. Delayed-type hypersensitivity induced in immunodeficient mice with syngeneic modified self antigens: a suggestive model of autoimmune response.
Tarcic N; Naor D
Eur J Immunol; 1982 Nov; 12(11):961-6. PubMed ID: 6983970
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of experimental autoimmune dacryoadenitis in susceptible and resistant mice.
Liu SH; Zhou DH; Hess AD
Cell Immunol; 1993 Sep; 150(2):311-20. PubMed ID: 8370074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
